Lessee, Operating Lease, Liability, to be Paid of Evoke Pharma Inc from 31 Dec 2024 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Evoke Pharma Inc quarterly Lessee, Operating Lease, Liability, to be Paid in USD history and change rate from 31 Dec 2024 to 30 Sep 2025.
  • Evoke Pharma Inc Lessee, Operating Lease, Liability, to be Paid for the quarter ending 30 Sep 2025 was $120,516.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)

Evoke Pharma Inc Quarterly Lessee, Operating Lease, Liability, to be Paid (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $120,516 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $139,886 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $159,258 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $178,629 31 Dec 2024 10-K 13 Mar 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.